Atlas of Genetics and Cytogenetics in Oncology and Haematology


Home   Genes   Leukemias   Solid Tumors   Cancer-Prone   Deep Insight   Case Reports   Journals  Portal   Teaching   

X Y 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 NA

ZNF793 (zinc finger protein 793)

Identity

Alias (NCBI)-
HGNC (Hugo) ZNF793
LocusID (NCBI) 390927
Atlas_Id 76410
Location 19q13.12  [Link to chromosome band 19q13]
Location_base_pair Starts at 37506939 and ends at 37543333 bp from pter ( according to hg38-Dec_2013)
Fusion genes
(updated 2017)
Data from Atlas, Mitelman, Cosmic Fusion, Fusion Cancer, TCGA fusion databases with official HUGO symbols (see references in chromosomal bands)
ZNF793 (19q13.12)::ZYG11B (1p32.3)

Note

Non-annotated gene. Preliminary data : if you are an author
who wish to write a full paper/card on this gene, go to  How to contribute

DNA/RNA

 



External links

 

Nomenclature
HGNC (Hugo)ZNF793   33115
Cards
Entrez_Gene (NCBI)ZNF793    zinc finger protein 793
Aliases
GeneCards (Weizmann)ZNF793
Ensembl hg19 (Hinxton)ENSG00000188227 [Gene_View]
Ensembl hg38 (Hinxton)ENSG00000188227 [Gene_View]  ENSG00000188227 [Sequence]  chr19:37506939-37543333 [Contig_View]  ZNF793 [Vega]
ICGC DataPortalENSG00000188227
TCGA cBioPortalZNF793
AceView (NCBI)ZNF793
Genatlas (Paris)ZNF793
SOURCE (Princeton)ZNF793
Genetics Home Reference (NIH)ZNF793
Genomic and cartography
GoldenPath hg38 (UCSC)ZNF793  -     chr19:37506939-37543333 +  19q13.12   [Description]    (hg38-Dec_2013)
GoldenPath hg19 (UCSC)ZNF793  -     19q13.12   [Description]    (hg19-Feb_2009)
GoldenPathZNF793 - 19q13.12 [CytoView hg19]  ZNF793 - 19q13.12 [CytoView hg38]
ImmunoBaseENSG00000188227
Genome Data Viewer NCBIZNF793 [Mapview hg19]  
Gene and transcription
Genbank (Entrez)AK131417 AK303740 BC150303 BE219465 BU683546
RefSeq transcript (Entrez)NM_001013659
Consensus coding sequences : CCDS (NCBI)ZNF793
Gene ExpressionZNF793 [ NCBI-GEO ]   ZNF793 [ EBI - ARRAY_EXPRESS ]   ZNF793 [ SEEK ]   ZNF793 [ MEM ]
Gene Expression Viewer (FireBrowse)ZNF793 [ Firebrowse - Broad ]
GenevisibleExpression of ZNF793 in : [tissues]  [cell-lines]  [cancer]  [perturbations]  
BioGPS (Tissue expression)390927
GTEX Portal (Tissue expression)ZNF793
Human Protein AtlasENSG00000188227-ZNF793 [pathology]   [cell]   [tissue]
Protein : pattern, domain, 3D structure
UniProt/SwissProtQ6ZN11   [function]  [subcellular_location]  [family_and_domains]  [pathology_and_biotech]  [ptm_processing]  [expression]  [interaction]
NextProtQ6ZN11  [Sequence]  [Exons]  [Medical]  [Publications]
With graphics : InterProQ6ZN11
PhosPhoSitePlusQ6ZN11
Domaine pattern : Prosite (Expaxy)KRAB (PS50805)    ZINC_FINGER_C2H2_1 (PS00028)    ZINC_FINGER_C2H2_2 (PS50157)   
Domains : Interpro (EBI)KRAB    KRAB_dom_sf    Znf_C2H2_sf    Znf_C2H2_type   
Domain families : Pfam (Sanger)KRAB (PF01352)    zf-C2H2 (PF00096)   
Domain families : Pfam (NCBI)pfam01352    pfam00096   
Domain families : Smart (EMBL)KRAB (SM00349)  ZnF_C2H2 (SM00355)  
Conserved Domain (NCBI)ZNF793
SuperfamilyQ6ZN11
AlphaFold pdb e-kbQ6ZN11   
Human Protein Atlas [tissue]ENSG00000188227-ZNF793 [tissue]
HPRD18402
Protein Interaction databases
DIP (DOE-UCLA)Q6ZN11
IntAct (EBI)Q6ZN11
BioGRIDZNF793
STRING (EMBL)ZNF793
ZODIACZNF793
Ontologies - Pathways
QuickGOQ6ZN11
Ontology : AmiGORNA polymerase II cis-regulatory region sequence-specific DNA binding  DNA-binding transcription factor activity, RNA polymerase II-specific  nucleus  regulation of transcription by RNA polymerase II  metal ion binding  
Ontology : EGO-EBIRNA polymerase II cis-regulatory region sequence-specific DNA binding  DNA-binding transcription factor activity, RNA polymerase II-specific  nucleus  regulation of transcription by RNA polymerase II  metal ion binding  
NDEx NetworkZNF793
Atlas of Cancer Signalling NetworkZNF793
Wikipedia pathwaysZNF793
Orthology - Evolution
OrthoDB390927
GeneTree (enSembl)ENSG00000188227
Phylogenetic Trees/Animal Genes : TreeFamZNF793
Homologs : HomoloGeneZNF793
Homology/Alignments : Family Browser (UCSC)ZNF793
Gene fusions - Rearrangements
Fusion : QuiverZNF793
Polymorphisms : SNP and Copy number variants
NCBI Variation ViewerZNF793 [hg38]
dbSNP Single Nucleotide Polymorphism (NCBI)ZNF793
dbVarZNF793
ClinVarZNF793
MonarchZNF793
1000_GenomesZNF793 
Exome Variant ServerZNF793
GNOMAD BrowserENSG00000188227
Varsome BrowserZNF793
ACMGZNF793 variants
VarityQ6ZN11
Genomic Variants (DGV)ZNF793 [DGVbeta]
DECIPHERZNF793 [patients]   [syndromes]   [variants]   [genes]  
CONAN: Copy Number AnalysisZNF793 
Mutations
ICGC Data PortalZNF793 
TCGA Data PortalZNF793 
Broad Tumor PortalZNF793
OASIS PortalZNF793 [ Somatic mutations - Copy number]
Somatic Mutations in Cancer : COSMICZNF793  [overview]  [genome browser]  [tissue]  [distribution]  
Somatic Mutations in Cancer : COSMIC3DZNF793
Mutations and Diseases : HGMDZNF793
LOVD (Leiden Open Variation Database)[gene] [transcripts] [variants]
BioMutaZNF793
DgiDB (Drug Gene Interaction Database)ZNF793
DoCM (Curated mutations)ZNF793
CIViC (Clinical Interpretations of Variants in Cancer)ZNF793
Cancer3DZNF793
Impact of mutations[PolyPhen2] [Provean] [Buck Institute : MutDB] [Mutation Assessor] [Mutanalyser]
Diseases
OMIM
Orphanet
DisGeNETZNF793
MedgenZNF793
Genetic Testing Registry ZNF793
NextProtQ6ZN11 [Medical]
GENETestsZNF793
Target ValidationZNF793
Huge Navigator ZNF793 [HugePedia]
ClinGenZNF793
Clinical trials, drugs, therapy
MyCancerGenomeZNF793
Protein Interactions : CTDZNF793
Pharm GKB GenePA162410548
PharosQ6ZN11
Clinical trialZNF793
Miscellaneous
canSAR (ICR)ZNF793
HarmonizomeZNF793
ARCHS4ZNF793
DataMed IndexZNF793
Probes
Litterature
PubMed6 Pubmed reference(s) in Entrez
GeneRIFsGene References Into Functions (Entrez)
EVEXZNF793
Genes in titleautomatic search in PubMed
REVIEW articlesautomatic search in PubMed
Last year publicationsautomatic search in PubMed

Search in all EBI   NCBI

© Atlas of Genetics and Cytogenetics in Oncology and Haematology
indexed on : Sun Jan 16 19:34:12 CET 2022

Home   Genes   Leukemias   Solid Tumors   Cancer-Prone   Deep Insight   Case Reports   Journals  Portal   Teaching   

For comments and suggestions or contributions, please contact us

jlhuret@AtlasGeneticsOncology.org.